Drug development from marine natural products

Tadeusz F. Molinski,Doralyn S. Dalisay,Sarah L. Lievens,Jonel P. Saludes
DOI: https://doi.org/10.1038/nrd2487
IF: 112.288
2008-12-19
Nature Reviews Drug Discovery
Abstract:Key PointsThe large-scale collection, screening and discovery of novel marine natural products has propelled new chemical entities into the clinic for the treatment of pain, cancer and other disease states.What is the status of discovery of 'drugs from the sea' and what hope do they offer for the alleviation of human suffering? The first two new drugs derived from marine organisms have now been approved — one for cancer and the other for chronic pain.Other natural-product-inspired drugs, such as the anticancer compound eribulin mesylate, are in the pipeline.We present the history and current stage of development for a selection of marine natural products, and examine the obstacles in their development into drugs.We also discuss how new technologies in analytical sciences and 'genomic mining' are accelerating the pace of discovery.
pharmacology & pharmacy,biotechnology & applied microbiology
What problem does this paper attempt to address?